Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis

These findings highlight MCT4 as a central regulator of RA proliferation and a promising therapeutic target.